Anteilseigner
Peter M. Hecht,
PhD (13,93 %) Slate Path Capital LP (13,21 %) MFN Partners Management LP (6,25 %) Tyndall Management LLC (6,08 %) Fidelity Management & Research Co. LLC (5,99 %) Invus Public Equities Advisors LLC (5,13 %) American Endowment Foundation (4,91 %) Errol B. de Souza (1,84 %) Terrance G. McGuire (1,55 %) Geode Capital Management LLC (1,18 %) The Vanguard Group, Inc. (0,87 %) Dina Katabi,
phD (0,74 %) Michael J. Higgins (0,74 %) BlackRock Fund Advisors (0,63 %) TrustCore Financial Services LLC (Old) (0,54 %) UBS Securities LLC (0,09 %) Marsha H. Fanucci,
MBA (0,03 %)
Kontakt
Cyclerion Therapeutics Inc.